This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2005-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2009
Title: The Innovative Contributions of Philippe Jean Gervais Ghislain Permanne
Introduction: Philippe Jean Gervais Ghislain Permanne is a notable inventor based in Rixensart, Belgium. He has made significant strides in the field of biotechnology, particularly in the development of vaccines and protein purification techniques. With two patents to his name, Permanne's work demonstrates a commitment to advancing medical science and enhancing health outcomes.
Latest Patents: Permanne's latest patent focuses on a vaccine for the prevention and treatment of HIV infection. This invention involves novel HIV polypeptide and polynucleotide fusions of Gag, Pol, and Nef, which are useful in immunogenic compositions and vaccines. Specifically, it relates to a polypeptide comprising Nef or an immunogenic fragment thereof, alongside p17 Gag and/or p24 Gag or their immunogenic fragments, strategically positioned with an HIV antigen between them. Additionally, the polypeptide may include Pol or reverse transcriptase (RT) or any immunogenic fragments thereof. Another important patent by Permanne introduces a process to concentrate insoluble proteins through vibrating membrane filtration, a method that enhances the purification of protein extracts by utilizing a hydrophilic membrane.
Career Highlights: Permanne is currently associated with GlaxoSmithKline Biologicals SA, a leading pharmaceutical company known for its research and development in vaccines and biotechnology. His contributions to innovative vaccine formulations and protein purification methods underline the importance of his work in the pharmaceutical industry.
Collaborations: Throughout his career, Permanne has collaborated with esteemed colleagues such as Helge Abrecht and Martine Delchambre. These collaborations highlight the team-oriented nature of research and innovation within the field, leading to groundbreaking advancements and strengthening the overall impact of their work.
Conclusion: Philippe Jean Gervais Ghislain Permanne exemplifies the vital role of inventors in the healthcare sector. His innovative patents in vaccine development and protein purification not only showcase his expertise but also contribute significantly to ongoing efforts in combating diseases. As he continues his work, Permanne's influence is expected to resonate in both scientific communities and the lives of individuals across the globe.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile